BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fernández-Murga ML, Petrov PD, Conde I, Castell JV, Goméz-Lechón MJ, Jover R. Advances in drug-induced cholestasis: Clinical perspectives, potential mechanisms and in vitro systems. Food Chem Toxicol 2018;120:196-212. [PMID: 29990576 DOI: 10.1016/j.fct.2018.07.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cuykx M, Beirnaert C, Rodrigues RM, Laukens K, Vanhaecke T, Covaci A. Untargeted liquid chromatography-mass spectrometry metabolomics to assess drug-induced cholestatic features in HepaRG® cells. Toxicol Appl Pharmacol 2019;379:114666. [PMID: 31323262 DOI: 10.1016/j.taap.2019.114666] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Li W, Yuan F, Wang LY. Mechanism, prevention, and treatment of drug-induced cholestasis. Shijie Huaren Xiaohua Zazhi 2019; 27(21): 1295-1303 [DOI: 10.11569/wcjd.v27.i21.1295] [Reference Citation Analysis]
3 Potmešil P, Szotkowská R. Drug-induced liver injury after switching from tamoxifen to anastrozole in a patient with a history of breast cancer being treated for hypertension and diabetes. Ther Adv Chronic Dis 2020;11:2040622320964152. [PMID: 33240477 DOI: 10.1177/2040622320964152] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gao T, Liao W, Lin L, Zhu Z, Lu M, Fu C, Xie T. Curcumae rhizoma and its major constituents against hepatobiliary disease: Pharmacotherapeutic properties and potential clinical applications. Phytomedicine 2022;102:154090. [DOI: 10.1016/j.phymed.2022.154090] [Reference Citation Analysis]
5 Halawi A, Ibrahim N, Bitar R. Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature. Acta Gastroenterol Belg 2021;84:477-86. [PMID: 34599573 DOI: 10.51821/84.3.013] [Reference Citation Analysis]
6 Caroleo B, Caroleo MC, Cimellaro A, Colangelo L, Perticone M, Di Mizio G, De Sarro G, Gallelli L. Glecaprevir/Pibrentasvir Induced Cholestatic Jaundice in a HCV Patient with Renal Failure. A Case Presentation. Curr Drug Saf 2019;14:67-71. [PMID: 30444202 DOI: 10.2174/1574886313666181116100452] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Esmail MM, Saeed NM, Michel HE, El-Naga RN. The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways. Toxicol Lett 2021;347:23-35. [PMID: 33961984 DOI: 10.1016/j.toxlet.2021.04.018] [Cited by in F6Publishing: 1] [Reference Citation Analysis]